{
    "Trade/Device Name(s)": [
        "Medisign GH81 Blood Glucose Monitoring System",
        "Medisign GH82 Blood Glucose Monitoring System",
        "Medisign GH83 Blood Glucose Monitoring System",
        "Medisign GH81 BT Blood Glucose Monitoring System",
        "Medisign GH82 BT Blood Glucose Monitoring System",
        "Medisign GH83 BT Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Tianjin Empecs Medical Device Co., Ltd.",
    "510(k) Number": "K162564",
    "Predicate Device Reference 510(k) Number(s)": [
        "K150214"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "May 4, 2017",
    "Summary Letter Received Date": "May 5, 2017",
    "Submission Date": "June 06, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Medisign GH81 Blood Glucose Meter",
        "Medisign GH82 Blood Glucose Meter",
        "Medisign GH83 Blood Glucose Meter",
        "Medisign GH81 BT Blood Glucose Meter",
        "Medisign GH82 BT Blood Glucose Meter",
        "Medisign GH83 BT Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric detection",
        "Flavin adenine dinucleotide-Glucose dehydrogenase (FAD-GDH)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Software",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Medisign GH81, GH82, GH83, and GH81 BT, GH82 BT, GH83 BT Blood Glucose Monitoring Systems for quantitative measurement of glucose in capillary whole blood using amperometric FAD-GDH method",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from fingertip, palm, and forearm for self-testing by people with diabetes at home to monitor diabetes control; single patient use only; not for diagnosis/screening of diabetes or neonatal use; alternative site testing for steady-state glucose levels",
    "fda_folder": "Clinical Chemistry"
}